Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Disease Control and Quality of Life at 8 Years

被引：1
|
作者：
Katz, A. [1 ]
Kang, J. [1 ]
机构：
[1] FROS Radiat Oncol & CyberKnife Ctr, Flushing, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2474
引用
收藏
页码：E187 / E187
页数：1
相关论文
共 50 条
  • [1] Toxicity and Quality of Life After Hypofractionated Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
    Seymour, Z. A.
    Chang, A.
    Roach, M.
    Gottschalk, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S604 - S604
  • [2] Stereotactic Body Radiation Therapy for Low- to Intermediate-risk Prostate Adenocarcinoma
    Jeong, Bae-Kwon
    Jeong, Hojin
    Ha, In Bong
    Choi, Hoon Sik
    Kam, Sung Chul
    Hwa, Jeong Seok
    Hyun, Jae Seog
    Chung, Ky Hyun
    Choi, See Min
    Kang, Ki Mun
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (06) : 710 - 715
  • [3] Stereotactic Body Radiation Therapy for Low-, Intermediate-, and High-Risk Prostate Cancer: Disease Control and Quality of Life at 6 Years
    Katz, A.
    Kang, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S24 - S25
  • [4] Stereotactic body radiation therapy for low-, intermediate- and high-risk prostate cancer: Disease control and quality of life at 9 years
    Katz, Alan J.
    Kang, Josephine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer
    Kishan, Amar U.
    King, Christopher R.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2017, 27 (03) : 268 - 278
  • [6] Quality of Life Outcomes for Low- and Intermediate-Risk Prostate Cancer Patients Treated With 5-Fraction Stereotactic Body Radiation Therapy
    Kaplan, I. D.
    Meier, R.
    Beckman, A. C.
    Henning, G.
    Woodhouse, S. A.
    Williamson, S. K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E249 - E249
  • [7] Toxicity and Quality of Life Report of a Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) for Low- and Intermediate-Risk Prostate Cancer
    Boyer, M. J.
    Rushing, C.
    Peterson, B.
    Papagikos, M. A.
    Kiteley, R. A.
    Lee, W. R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E256 - E257
  • [8] STEREOTACTIC BODY RADIATION THERAPY IN LOW- AND INTERMEDIATE-RISK PROSTATE CANCER: RESULTS OF PHASE II STUDY
    Franzese, Ciro
    D'agostino, Giuseppe Roberto
    Liardo, Rocco Luca Emanuele
    Reggiori, Giacomo
    Navarria, Pierina
    Cristina, Iftode
    De Rose, Fiorenza
    Franceschini, Davide
    Tozzi, Angelo
    Comito, Tiziana
    Ascolese, Anna Maria
    Tomatis, Stefano
    Cozzi, Luca
    Scorsetti, Marta
    [J]. ANTICANCER RESEARCH, 2016, 36 (05) : 2545 - 2545
  • [9] Stereotactic Body Radiation Therapy for Low, Intermediate, and High-risk Prostate Cancer: Disease Control and Quality of Life
    Katz, A. J.
    Santoro, M.
    DiBlasio, F.
    Ashley, R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S100 - S100
  • [10] Low- and Intermediate-Risk Prostate Cancer. Stereotactic Body Radiation Therapy. Our experience.
    Garcia Aguilera, C.
    Mendez Villamon, A.
    Flamarique Andueza, S.
    Villa Gazulla, D.
    Escuin Troncho, C.
    Ponce Ortega, J. M.
    Puertas Valino, M. M.
    Tejedor Gutierrez, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S616 - S616
12345